Ajou University repository

Novel fungal diversity: A new prospect for the commercial production of future anti-cancer compounds
Citations

SCOPUS

3

Citation Export

Publication Year
2024-06-01
Publisher
Elsevier Ltd
Citation
Fungal Biology Reviews, Vol.48
Keyword
Anticancerous compoundsCancerEndophytic fungiExtremophilic fingiFungal diversity
All Science Classification Codes (ASJC)
Microbiology
Abstract
Cancer is a multifaceted disease that closes the curtains of life of infected individuals globally. By 2030, it is predicted that there will be a rise in new cancer cases and cancer deaths of up to 26 million and 17 million per year, respectively. Growing demand for chemotherapy over the past few years and a constrained supply of different anti-cancer drugs have ultimately driven up the price of various anticancerous drugs available in the clinical market. In order to address the widespread concerns about increasing cancer cases and the current costs of chemotherapy, researchers have explored extreme fungal diversity, which has significant source for the sustainable alternative production of anti-cancerous agents with higher yields, lower production costs, and less time consumption. In addition to extremophilic bacteria, which have been most extensively studied, extremophilic fungi are also ubiquitous but have received less attention in the past as a source of novel bioactive compounds. Along with the diversity of extremophilic fungi, endophytic fungi also hold out a new, hope for the eventual finding of cancer treatments. The major components of novel fungi exhibiting anti-cancerous effects are alkaloids, terpenoids, glycosides, saponin, peptides, steroids, phenols, quinones, and flavonoids. Therefore, the focus of the current review is on the reported anti-cancerous compounds produced by novel extremophilic and endophytic fungi, which offers a promising prospect for their bench-scale commercial production. The prospects and constraints for further clinical development along with the cost analysis of available commercial drugs in comparison to those derived from fungi also discussed.
ISSN
1749-4613
Language
eng
URI
https://dspace.ajou.ac.kr/dev/handle/2018.oak/33950
DOI
https://doi.org/10.1016/j.fbr.2023.100355
Fulltext

Type
Review
Funding
This research was made possible by a grant from the Ministry of Education, Science, and Technology (MEST), financed by the National Research Foundation of Korea (NRF) (Grant Number: 2021R1A2C1007519) and the R&D Program of MOTIE/KEIT (Grant number: 20018132 and 20014350).Kwon-Young Choi reports financial support was provided by National Research Foundation of Korea. Kwon-Young Choi reports financial support was provided by Korea Evaluation Institute of Industrial Technology.The Department of Environmental and Safety Engineering at Ajou University in Suwon, South Korea, and the Department of Biotechnology at Shoolini University of Biotechnology and Management Sciences in Solan, Himachal Pradesh, India, have both provided the necessary resources for the study, and the authors want to thank them for their support. All the structures have been adopted from the PubChem, https://pubchem.ncbi.nlm.nih.gov/and modified for the creation of the images. In addition, we are grateful to all our laboratory colleagues and research personnel for their helpful advice and assistance.This research was made possible by a grant from the Ministry of Education, Science, and Technology (MEST) , financed by the National Research Foundation of Korea (NRF) (Grant Number: 2021R1A2C1007519 ) and the R&D Program of MOTIE / KEIT (Grant number: 20018132 and 20014350 ).
Show full item record

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Choi, Kwon Young Image
Choi, Kwon Young최권영
College of Bio-convergence Engineering
Read More

Total Views & Downloads

File Download

  • There are no files associated with this item.